Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groupsATTARBASCHI, Andishe; MORAK, Maria; SCHWAB, Claire et al.British journal of haematology. 2012, Vol 158, Num 6, pp 772-777, issn 0007-1048, 6 p.Article

Risk-Directed Treatment Intensification Significantly Reduces the Risk of Relapse Among Children and Adolescents With Acute Lymphoblastic Leukemia and Intrachromosomal Amplification of Chromosome 21: A Comparison of the MRC ALL97/99 and UKALL2003 TrialsMOORMAN, Anthony V; ROBINSON, Hazel; SCHWAB, Claire et al.Journal of clinical oncology. 2013, Vol 31, Num 27, pp 3389-3396, issn 0732-183X, 8 p.Article

Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemiaRUSSELL, Lisa J; CAPASSO, Melania; GUTTERY, David S et al.Blood. 2009, Vol 114, Num 13, pp 2688-2698, issn 0006-4971, 11 p.Article

IGH@ Translocations, CRLF2 Deregulation, and Microdeletions in Adolescents and Adults With Acute Lymphoblastic LeukemiaMOORMAN, Anthony V; SCHWAB, Claire; GOLDSTONE, Anthony H et al.Journal of clinical oncology. 2012, Vol 30, Num 25, pp 3100-3108, issn 0732-183X, 9 p.Article

Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trialENSOR, Hannah M; SCHWAB, Claire; HARRISON, Christine J et al.Blood. 2011, Vol 117, Num 7, pp 2129-2136, issn 0006-4971, 8 p.Article

Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemiaRAND, Vikki; PARKER, Helen; RYAN, Sarra et al.Blood. 2011, Vol 117, Num 25, pp 6848-6855, issn 0006-4971, 8 p.Article